Greater Cannabis Company (GCAN) Revenue Growth (3y) (2020 - 2021)

Greater Cannabis Company (GCAN) Revenue Growth (3y) (2020 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 2.84%
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 4.19%
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 15.52%
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 14.49%
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 24.66%
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 2.94%
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -48.41%
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 7.85%
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 47.17%
10 Greater Cannabis Company - - - -

Historic Data

Download Data
DateValue
Jun 30, 2021 -17.46%
Jun 30, 2020 769.84%